New Market Report Now Available: Australia Pharmaceuticals & Healthcare Report Q2 2014
We have downgraded our Australia pharmaceutical forecast, following the release of the latest Pharmaceutical Benefits Scheme (PBS) expenditure. While demands for pharmaceuticals and healthcare services will remain high owing to the ageing population, we note that proposed changes to PBS pricing and reimbursement (via price disclosure) could potentially bring down drug prices further.
View full press release